Mechanisms by which pharmacologic agents may contribute to fatigue

PM & R : the Journal of Injury, Function, and Rehabilitation
Daniel A Zlott, Mary Byrne

Abstract

Fatigue is a common side effect of medications. This review summarizes some of the mechanisms by which drugs may cause fatigue. One major mechanism by which medications can cause fatigue is by central nervous system (CNS) depression. CNS depression can result from decreased excitatory activity, as is commonly seen with some anticholinergic agents, centrally acting alpha-agonists, and anticonvulsants. CNS depression can also result from increased inhibitory activity within the CNS, as is seen with benzodiazepines and barbiturates, which augment the effects of the inhibitory neurotransmitter, gamma-aminobutyric acid. Opioids also increase inhibitory CNS activity through their interactions with the various subtypes of opioid receptors. Acting outside of the CNS, medications may cause fatigue as a result of either a true or a functional anemia by a number of mechanisms. Bone marrow toxicity, which results in decreased hematopoiesis, is such a mechanism. This is commonly seen with antineoplastics agents, but can also be observed in association with a wide variety of medication classes, including anticonvulsants, antidepressants, and antimicrobial agents. Another way that medications can cause anemia is by increased red blood cell de...Continue Reading

References

Dec 18, 2004·Blood Reviews·Melanie J PercyTerry R J Lappin
May 29, 2008·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Jeffrey K Aronson

❮ Previous
Next ❯

Citations

Sep 21, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·José A LarrauriEdward D Levin
Aug 15, 2015·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Gita FatemiDebra K Weiner
Sep 13, 2015·Seizure : the Journal of the British Epilepsy Association·Alberto VerrottiGaetano Zaccara
May 7, 2015·Chemical Research in Toxicology·Victor MartínLuis M Botana
Mar 29, 2011·Archives of Physical Medicine and Rehabilitation·Ying GuoEduardo Bruera
Jul 27, 2010·PM & R : the Journal of Injury, Function, and Rehabilitation·Lynn H Gerber
Aug 3, 2011·AACN Advanced Critical Care·Ellyn E Matthews
Apr 1, 2015·British Journal of Haematology·Quentin A Hill, Adrian C Newland
May 7, 2015·Chemical Research in Toxicology·Víctor MartínLuís M Botana
Sep 21, 2013·European Journal of Pharmacology·Antonio SiniscalchiGiovambattista De Sarro
Jul 15, 2016·Stroke Research and Treatment·Amélie PonchelHilde Hénon
Sep 21, 2017·Journal of Occupational and Environmental Medicine·Michele Kowalski-McGrawPaul A Schulte
Nov 24, 2017·British Journal of Nursing : BJN·Ruff Jm Cajanding
Feb 12, 2020·Acta neurologica Belgica·Aslı Ece Çilliler, Bülent Güven
Nov 23, 2017·Frontiers in Medicine·Claudie HooperUNKNOWN MAPT/DSA Study Group
Feb 6, 2018·Journal of Hospice and Palliative Nursing : JHPN : the Official Journal of the Hospice and Palliative Nurses Association·Joseph D PerazzoMaryjo Prince-Paul
Feb 27, 2021·The Journal of the American Osteopathic Association·James William Price
May 11, 2021·Journal of Food Science and Technology·Tao FengJunming Mo
Aug 8, 2021·Journal of Advanced Nursing·Suzanne BenchLouise Stayt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

Expert Review of Pharmacoeconomics & Outcomes Research
Joachim Weis
Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics
Brian S Meldrum, Michael A Rogawski
Pharmacological Research : the Official Journal of the Italian Pharmacological Society
A SiniscalchiE Santangelo
© 2021 Meta ULC. All rights reserved